Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort.
Ehsan IrajizadJohannes F FahrmannTracey L MarshJody V VykoukalJennifer B DennisonJames P LongKim-Anh DoZiding FengSamir M HanashEdwin Justin OstrinPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
identifies individuals at high risk of a lethal lung cancer.